Scarica l'app Stockscreener
39.99
5.71%
2.16
Precedente Chiudi:
$37.83
Aprire:
$38.54
Volume 24 ore:
922.26K
Relative Volume:
1.61
Capitalizzazione di mercato:
$1.82B
Reddito:
$1.23B
Utile/perdita netta:
$20.43M
Rapporto P/E:
90.66
EPS:
0.4411
Flusso di cassa netto:
$95.39M
1 W Prestazione:
-4.67%
1M Prestazione:
-7.26%
6M Prestazione:
-7.58%
1 anno Prestazione:
+36.72%
Intervallo 1D:
$38.39
$40.22
Intervallo di 1 settimana:
$36.55
$43.32
Portata 52W:
$26.84
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
39.99 | 1.72B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
162.17 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.08 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.32 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
86.97 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
68.35 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2026-01-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Reiterato | Wells Fargo | Underweight |
| 2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Iniziato | BofA Securities | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-12-06 | Ripresa | Wells Fargo | Overweight |
| 2021-06-09 | Iniziato | JP Morgan | Neutral |
| 2021-05-24 | Iniziato | BTIG Research | Buy |
| 2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-02-07 | Reiterato | Dougherty & Company | Buy |
| 2019-11-21 | Reiterato | Dougherty & Company | Buy |
| 2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-03-07 | Reiterato | Dougherty & Company | Buy |
| 2018-06-29 | Ripresa | The Benchmark Company | Buy |
| 2017-09-05 | Reiterato | The Benchmark Company | Buy |
| 2017-07-28 | Reiterato | Dougherty & Company | Buy |
| 2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Iniziato | Dougherty & Company | Buy |
| 2016-12-06 | Reiterato | The Benchmark Company | Buy |
| 2016-07-07 | Reiterato | FBR Capital | Outperform |
| 2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
| 2016-01-07 | Iniziato | The Benchmark Company | Buy |
| 2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
| 2015-10-30 | Reiterato | FBR Capital | Outperform |
| 2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
What Omnicell (OMCL)'s New Specialty Pharmacy Leader Means For Shareholders - simplywall.st
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Oric Pharmaceuticals (ORIC) and Pfizer (PFE) - The Globe and Mail
Omnicell (NASDAQ:OMCL) Trading Down 4.9%Time to Sell? - MarketBeat
Omnicell (OMCL) is a top-ranked value stock: Should you buy? - MSN
Transcript : Omnicell, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 03 - marketscreener.com
Omnicell: Why I’m Long Into Q2 Earnings Despite The Bookings Wobble (NASDAQ:OMCL) - Seeking Alpha
Earnings Preview: Omnicell to Report Financial Results Pre-market on April 28 - Moomoo
Omnicell appoints Dan Mandoli to lead specialty pharmacy unit - Investing.com UK
Omnicell, Inc. Announces Appointment of Dan Mandoli to Senior Vice President and General Manager, Specialty Pharmacy Services - marketscreener.com
Omnicell appoints Dan Mandoli to lead specialty pharmacy unit By Investing.com - Investing.com South Africa
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business - 巴士的報
Intech Investment Management LLC Sells 30,447 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell (OMCL) may find a bottom soon, here's why you should buy the stock now - MSN
Omnicell Shareholders Back Governance Amendment And Long Term Growth Focus - Yahoo Finance
Should Omnicell’s (OMCL) Governance Moves and Conference Spotlight Recast Its Recurring Revenue Narrative? - Sahm
OMCL Technical Analysis & Stock Price Forecast - Intellectia AI
Why (OMCL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Q1 2026 Earnings Analysis: Healthcare Tech for Providers Sector PerformanceNews and Statistics - IndexBox
Wall Street Analysts Predict a 40.57% Upside in Omnicell (OMCL): Here's What You Should Know - Yahoo Finance
Omnicell (OMCL) is a top-ranked momentum stock: Should you buy? - MSN
A Look at Omnicell Inc (OMCL) After 4.1% Gain -- GF Value $38.65 vs Price $43.62 - GuruFocus
Is Omnicell Stock a Smart Addition to Your Portfolio Now? - Zacks Investment Research
Omnicell (OMCL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - sharewise.com
Omnicell (OMCL) director receives 4,785-share stock grant - Stock Titan
Omnicell (OMCL) director granted 4,845 restricted shares as board pay - Stock Titan
Omnicell (OMCL) director awarded 4,603 restricted shares as board compensation - Stock Titan
Omnicell (OMCL) director Mark Parrish receives 4,845-share board compensation grant - Stock Titan
Omnicell (NASDAQ: OMCL) director receives 4,603-share restricted stock award - Stock Titan
[Form 4] OMNICELL, INC. Insider Trading Activity - Stock Titan
Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - BioSpace
Omnicell (OMCL) director Joanne Bauer receives 5,027-share equity grant for board service - Stock Titan
Omnicell Inc stock (US6821321088): Shares little changed as investors look beyond last earnings upda - AD HOC NEWS
Omnicell Inc stock (US6821321088): OMCL gains on Nasdaq as short interest edges above 6 percent - AD HOC NEWS
Omnicell (OMCL) up 0.1% since last earnings report: Can it continue? - MSN
Surging earnings estimates signal upside for Omnicell (OMCL) stock - MSN
Omnicell lifts 2026 non-GAAP EPS outlook to $1.80-$2.00 as Titan XT shipments are planned for 2H 2026 - MSN
3 Healthcare Stocks We Think Twice About - Yahoo Finance
A Look at Omnicell Inc (OMCL) After 3.6% Gain -- GF Value $38.63 vs Price $44.73 - GuruFocus
Omnicell (OMCL) Up 0.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Omnicell Company Profile & Introduction - Moomoo
Omnicell, Inc. Files Form 8-K Announcing Amended Certificate of Incorporation and Annual Meeting Results - Minichart
Omnicell Governance Vote Sparks Fresh Market Focus - Kalkine Media
Omnicell (NASDAQ: OMCL) adds 1.6M equity plan shares, amends charter - Stock Titan
Omnicell Inc. (OMCL) Q1 2026 Earnings: EPS Surges Past Estimates, Stock SlipsQuarterly Profit Report - The Legal Advocate
Understanding Momentum Shifts in (OMCL) - Stock Traders Daily
Omnicell Stock Surges 57.3% in a Year: What's Driving It? - Yahoo Finance
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
3.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):